MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour-suppressive activity.
Hyeonhee LeeBum-Chan ParkJong Soon KangYeongmi CheonSoojin LeePil Jae MaengPublished in: Cell proliferation (2020)
We report that MAMDC2 has a tumour-suppressive role and, as a secretory protein, it might be useful as a biomarker for breast cancer treatment.
Keyphrases